Further exploration and investigation of rs12740374 and rs7528419, along with their corresponding genes PSRC1, CELSR2, and MYBPHL, are recommended as potential pharmacological targets for the treatment of CHD and MI. This evidence concerns the gene MYBPHL and myocardial infarction.